For a long time, there have been rumours that Russian President Vladimir Putin uses botox. And, with Russia’s invasion of Ukraine, a slew of jokes has sprung up around the rumour. Even if the rumours are genuine, Putin may have to put an end to the treatments shortly.
Putin may no longer be allowed to use botox as a result of Western sanctions against Russia, according to sources. This is owing to statements made by several pharmaceutical corporations in the aftermath of financial penalties.
Last week, Eli Lilly and Co, Novartis, Abbvie Inc, and other pharmaceutical companies announced that they would continue to deliver vital drugs for cancer and diabetes therapy, but that non-essential treatments would be discontinued.
Eli Lilly and Co, Novartis, and Abbvie Inc are among the businesses that, according to Reuters, indicated last week that they will continue to deliver crucial cancer and diabetes treatments while discontinuing “non-essential” items.
Putin has been taking botox for quite some time, according to both The Daily Beast and The Guardian.
In a storey headed “What has happened with Putin’s face?” published ten years ago, The Guardian noted that Russia’s liberal New Times magazine has renewed the notion.
It talked with four plastic doctors, all of whom said that Russian President Vladimir Putin had had cosmetic surgery. Botox injections in his forehead, an eye-lift on his lower lids, and a firming filler injection into his cheekbones were all possibilities.
AbbVie, a worldwide pharmaceutical firm that makes Botox, said on its website that it has temporarily halted operations in Russia for its aesthetics medicines, including Botox, while the Ukraine situation progresses. According to the corporation, it does not have any production units in the area. AbbVie will continue to manufacture and supply life-saving medications to Russian patients.
Drugmakers are having to walk a delicate line between boycotting Russia and continuing to supply ordinary individuals with crucial pharmaceuticals and pharmaceutical equipment, despite tremendous public pressure on western corporations to stop doing business there. Abbott said this week that it was stopping non-essential activity in Russia, including new investments, business growth, and advertising. Abbott has officially criticised the conflict. However, the business stated that it will continue to deliver life-sustaining drugs in Russia for cancer maintenance and organ function.
Other pharmaceutical corporations, such as Bayer in Germany, Eli Lilly in the United States, and Pfizer in the United Kingdom, have adopted similar positions. They’re halting non-essential business in Russia while continuing to provide critical medications and gadgets.
